본문으로 바로가기
현재 위치:
진료안내
진료과
의료진 소개
카카오 프린트

의료진 소개

최용범 의사
최용범 [ 피부과 ]

건선, 색소성질환, 성인아토피피부염

고맙습니다 진료예약
외래진료 외래진료 특수클리닉 특수클리닉
진료일정 04
진료일정(날짜, 오전, 오후)
날짜
오전
오후

논문

논문
  • Kim JH, Yu, DA, Choe YB, Son HS, Lee YW. Assessment of effects of low-level light therapy on scalp condition and hair growth.  Indian Journal of Dermatology. 2023 Jul-Aug;68(4):e487. 
  • Cho YA, Yu DA, Lee YW, Sung JY, Kim CY, Hong JY, Kim SM, Choe YB. Serious infections and tuberculosis in psoriasis patients receiving systemic therapy in Korea: a nationwide population-based cohort study.  European Journal of Dermatology. 2023 May-Jun;33(3):287-95. 
  • Choi YB. Basic Therapeutic Approach for Patients with Plaque Psoriasis: Korean Expert Consensus Using the Modified Delphi Method.  Annals of Dermatology. 2023 Jun;35(3):173-82. 
  • Kim SM, Yu DA, Lee YW, Cho YA, Sung JY, Kim CY, Choe YB. Increased Risk of Suicidality in Patients with Psoriasis: A Nationwide Cohort Study in Korea.  Journal of the European Academy of Dermatology and Venereology. 2023 Jan;37(1):75-84. 
  • Lee JS, Yoo DA, Choe YB, Son HS, Yoon IN, Shin JE, Lee YW. Analysis of the Microbiome of the Ear Canal in Normal Individuals and Patients with Chronic Otitis Externa.  Annals of Dermatology. 2022 Dec;34(6):461-71. 
  • Kim SM, Ahn J, Cho YA, Sung JY, Kim CY, Yu DA, Lee YW, Won S, Choe YB. Increased risk of suicidality in patients with psoriasis: A Nationwide cohort study in Korea.  Journal of the European Academy of Dermatology and Venereology. 2023 Jan;37:75-84. 
  • Hong JY, Yoo DA, Lee YW, Kim SM, Cho YA, Kim CY, Sung JY, Choe YB. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.  Scientific Reports. 2022 Nov;12(1):20690. 
  • Youn SW, Yu DY, Kim TY, Kim BS, Lee SC, Lee JH, Choe YB, Lee JH, Choi JH, Roh JY, Jo SJ, Lee ES, Shin MK, Lee MG, Jiang J, Lee Y. Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials.  Journal of Dermatological Treatment. 2022 Feb;33(1):535-541. 
  • Hong JR, Lee YW, Ahn KJ, Hong JY, Kim SM, Cho YA, Yang HS, Choe YB. The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study.  Scientific Reports. 2021 Apr;11(1):8588. 
  • Hur MS, Hong JY, Hong JR, Lee YW, Ahn KJ, Choe YB. Clinical characteristics of psoriatic patients with latent tuberculosis infection.  European Journal of Dermatology. 2020 Apr;10.1684. 
  • Choi BG, Hong JY, Hong JR, Hur MS, Kim SM, Lee YW, Ahn KJ, Choe YB. The IL17F His161Arg polymorphism, a potential risk locus for psoriasis, increases serum levels of interleukin-17F in an Asian population.  Scientific Reports. 2019 Dec;9(1):18921. 
  • Reich K, Song M, Li S, Jiang J, Youn SW, Tsai TF, Choe YB, Huang YH, Gordon KB. Consistent responses with guselkumab treatment in Asian and non-Asian patients with psoriasis: An analysis from VOYAGE 1 and VOYAGE 2.  Journal of Dermatology. 2019 Dec;46(12):1141-1152. 
  • Hong JR, Lee YW, Ahn KJ, Choe YB. Risk Factors for Increased Serum Creatinine Level in Patients with Psoriasis Treated with Cyclosporine in a Real-world Practice.  Dermatologic Therapy. 2019 May;32(3):e12875. 
  • Choe YB, Park CJ, et al. Usefulness of the Psoriatic Arthritis Screening and Evaluation Questionnaire to Monitor Disease Activity in Management of Patients with Psoriasis: Findings from the EPI-PSODE Study.  Annals of Dermatology. 2019 Feb;31(1):29-36. 
  • Youn SW, Lee JH, Yu DY, Kim Y, Kim BS, Seo SJ, Choe YB, Yun SK, Park J, Kim NI, Choi CW, Youn JI, Lee SJ, Lee MG, Kim KJ, Park CJ, Ro YS, Song HJ, Shin BS, Ahn SK, Lee JY, Won YH, Jang MS, Kim KH, Kim MH, Kim TY, Choi JH. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).  Journal of the European Academy of Dermatology and Venereology. 2018 Sep;32(9):1499-1506. 
  • Han SH, Choe YB, Ahn KJ, Hur MS, Kim MJ, Kim HR, Lee YW. Preliminary Study of Histamine H4 Receptor Expressed on Human CD4+ T cells and its Immunomodulatory Potency in the IL-17 Pathway of Psoriasis.  Journal of Dermatological Science. 2017 Oct;88(1):29-35. 
  • Chun JH, Yoon YH, Choe YB, Kang LH, Paik SY, Park CJ. Gene Expression Analysis of Inflammatory Cytokines in Korean Psoriatic Patients.  Annals of Dermatology. 2017 Aug;29(4):422-426. 
  • Song HJ, Park CJ, Kim TY, Choe YB, Lee SJ, Kim NI, Cho JW, Jeon JH, Jang MS, Youn JI, Kim MH, Park J, Kim KH, Kim BS, Youn SW, Lee JH, Lee MG, Ahn SK, Won YH, Yun SK, Shin BS, Seo SJ, Lee JY, Kim KJ, Ro YS, Kim Y, Yu DY, Choi JH. The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE).  Annals of Dermatology. 2017 Aug;29(4):462-470. 
  • Choi BG, Choe YB, Lee YW, Ahn KJ, Kim MJ, Yang HS. Assessment of Arterial Stiffness in Korean Patients With Psoriasis by Cardio-Ankle Vascular Index.  Angiology. 2017 Aug;68(7):608-613. 
  • Lee JH, Park CJ, Kim TY, Choe YB, Kim NI, Song HJ, Youn JI, Youn SW, Choi JH, Kim KJ. Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.  Journal of the European Academy of Dermatology and Venereology. 2017 Mar;31(3):483-489. 
  • Kim SY, Hur MS, Choi BG, Kim MJ, Lee YW, Ahn KJ, Choe YB. A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population.  Clinical and Experimental Immunology. 2017 Feb;187(2):251-258. 
  • Lee JH, Youn JI, Kim TY, Choi JH, Park CJ, Choe YB, Song HJ, Kim NI, Kim KJ, Lee JH, Yoo HJ. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.  BMC Dermatol. 2016 Jul;16(1):11. 
  • Roh NK, Han SH, Youn HJ, Kim YR, Lee YW, Ahn KJ, Choe YB. Tissue and Serum Inflammatory Cytokine Levels in Korean Psoriasis Patients: A Comparison between Plaque and Guttate Psoriasis.  Annals of Dermatology. 2015 Dec;27(6):738-743. 
  • Kim SY, Yang HS, Lee YW, Ahn KJ, Choe YB. Evaluation of the Beta Stiffness Index and Carotid Intima-Media Thickness in Asian Patients With Psoriasis.  Angiology. 2015 Oct;66(9):889-895. 
  • Youn SW, Kim BR, Lee JH, Song HJ, Choe YB, Choi JH, Kim NI, Kim KJ, Youn JI. Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report.  Annals of Dermatology. 2015 Apr;27(2):184-189. 
  • Hwang YJ, Jung HJ, Kim MJ, Roh NK, Jung JW, Lee YW, Ahn KJ, Choe YB. Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis.  Mediators of Inflammation. 2014;2014:268257. 
  • Choe YB, Hwang YJ, Hahn HJ, Jung JW, Jung HJ, Lee YW, Ahn KJ, Youn JI. A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.  British Journal of Dermatology. 2012 Oct;167(4):762–767. 
  • Tsai TF, Song M, Shen YK, Schenkel B, Choe YB, Kim NI, Lee JH, Lee JH, Song HJ, Youn JI; PEARL investigators. Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.  Journal of Drugs in Dermatology. 2012 Aug;11(8):943-949. 
  • Tsai TF, Ho JC, Song M, Szapary P, Guzzo C, Shen YK, Li S, Kim KJ, Kim TY, Choi JH, Youn JI; PEARL Investigators. Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL).  Journal of Dermatological Science. 2011 Sep;63(3):154-163.